Unitedhealth Group Inc (UNH) Stock Price & Analysis
Unitedhealth Group Inc (UNH) fell 0.67% to USD 420.74 as of July 25, 2026 at 01:13 UTC, according to Nexqual real-time market data.
UNH last closed at USD 423.56; the session ranged USD 419–429 on volume of 3,746,826 shares. Market capitalization is $382.09B, with a 52-week range of USD 234.6–461.62 (NYQ). Source: Nexqual, July 25, 2026 at 01:13 UTC.
Key Statistics (as of July 25, 2026 at 01:13 UTC)
| Price | USD 420.74 |
|---|---|
| Change | ▼ 0.67% (down) |
| Previous Close | USD 423.56 |
| Open | USD 425.24 |
| Day Range | USD 419 – 429 |
| 52-Week Range | USD 234.6 – 461.62 |
| Volume | 3,746,826 shares |
| Market Cap | $382.09B |
| Exchange | NYQ |
Technical Analysis (UNH)
Nexqual's technical model rates UNH "BUY" based on 4 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 01:13 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 50.85 (neutral) |
| vs SMA50 | Above (USD 407.6) |
| MACD | 5.72 (positive) |
Analyst Ratings (UNH)
Wall Street analysts rate UNH "Buy" based on 26 analysts, with a mean price target of USD 475.23 (range USD 313–529), per Nexqual as of July 25, 2026 at 01:13 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 26 |
| Mean Target | USD 475.23 |
| High Target | USD 529 |
| Low Target | USD 313 |
| Buy / Hold / Sell | 22 / 5 / 0 |
Earnings (UNH)
| Next Earnings Date | 2026-07-16 |
|---|---|
| EPS Estimate | USD 4.08 |
| Revenue Estimate | $111.49B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 6.38 vs est 4.92 ▲ beat |
| 2026-03-31 | USD 7.23 vs est 6.6 ▲ beat |
| 2025-12-31 | USD 2.11 vs est 2.11 ▲ beat |
| 2025-09-30 | USD 2.92 vs est 2.81 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:13 UTC.
Financials & Fundamentals (UNH)
| Total Revenue | $450.13B |
|---|---|
| Revenue Growth (YoY) | +0.40% |
| Gross Margin | +19.51% |
| Operating Margin | +7.13% |
| Profit Margin | +3.14% |
| ROE | +14.15% |
| Debt / Equity | 69.21 |
| Current Ratio | 0.78 |
| Total Cash | $31.47B |
| Total Debt | $73.33B |
| Free Cash Flow | $22.76B |
Source: Nexqual, July 25, 2026 at 01:13 UTC.
Financial Health Score (UNH)
Nexqual rates Unitedhealth Group Inc's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 01:13 UTC.
| Growth | Solid — Revenue +12% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 20%, operating 7% |
| Balance Sheet | Mixed — $31.5B cash vs $73.3B debt |
| Cash Flow | Solid — FCF $22.8B, 5% margin |
| Efficiency | Mixed — ROE 14%, ROA 4.4% |
Ownership (UNH)
| Insider Ownership | +0.24% |
|---|---|
| Institutional Ownership | +86.24% |
| Shares Outstanding | 908.14M |
| Float | 903.29M |
| Short % of Float | +2.26% |
Source: Nexqual, July 25, 2026 at 01:13 UTC.
Leadership (UNH)
Unitedhealth Group Inc is led by Stephen J. Hemsley (age 72), CEO & Non-Independent Non-Executive Chairman, per Nexqual as of July 25, 2026 at 01:13 UTC.
| CEO & Non-Independent Non-Executive Chairman | Stephen J. Hemsley (age 72) |
|---|---|
| Chief Financial Officer | Wayne Scott DeVeydt (age 55) |
| Senior Vice President of Capital Markets Communications & Investor Relations | Zachary William Sopcak |
| Executive Vice President & Senior Advisor | Richard J. Migliori (age 68) |
Major Backers & Investors (UNH)
Notable institutional backers of Unitedhealth Group Inc include Capital Group, Price (T.Rowe) Associates Inc, Charles Schwab Investment Management, Inc., according to Nexqual as of July 25, 2026 at 01:13 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Capital Group | 4.94% |
| Price (T.Rowe) Associates Inc | 2.3% |
| Charles Schwab Investment Management, Inc. | 2.29% |
| JPMorgan | 2.1% |
| Fidelity | 1.28% |
| WASHINGTON MUTUAL INVESTORS FUND | 0.98% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 15.75% |
| BlackRock | 9.4% |
| State Street | 6.2% |
| Geode Capital | 2.51% |
Source: Nexqual, July 25, 2026 at 01:13 UTC.
From Unitedhealth Group Inc's Latest SEC 10-K Filing (filed 2026-03-02)
Key Strengths & Strategy (as disclosed to the SEC)
- UnitedHealth Group Incorporated operates as a health care company in the United States and internationally.
- It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.
- The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities.
- The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LLY | Eli Lilly and Company | USD 1,196.03 | ▲ 2.84% |
| V | Visa Inc. | USD 355.74 | ▲ 0.66% |
| AVGO | Broadcom Inc. | USD 381.92 | ▼ 3.75% |
| CRM | Salesforce, Inc. | USD 163.66 | ▲ 0.4% |
| COST | Costco Wholesale Corporation | USD 935.03 | ▲ 0.83% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:13 UTC. This page is informational and not investment advice.